Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04609826
Title A Study of JNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

acute myeloid leukemia

chronic myelomonocytic leukemia

myelodysplastic syndrome

Therapies

JNJ74856665

Azacitidine + JNJ74856665

JNJ74856665 + Venetoclax

Age Groups: adult | senior
Covered Countries USA | FRA | ESP


No variant requirements are available.